News and Trends 25 Jul 2023
Triastek sees positive results from printed oral treatment for ulcerative colitis
Triastek, Inc. has completed its first in human study of its third 3D printing drug product, T21, designed to treat moderate to severe ulcerative colitis (UC). Imaging results from the…